NanoVibronix, Inc. (NAOV)
NASDAQ: NAOV · IEX Real-Time Price · USD
0.715
+0.016 (2.30%)
Jul 2, 2024, 4:30 PM EDT - Market closed
NanoVibronix Revenue
NanoVibronix had revenue of $2.85M in the twelve months ending March 31, 2024, with 241.73% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $921.00K with 160.17% year-over-year growth. In the year 2023, NanoVibronix had annual revenue of $2.28M with 203.59% growth.
Revenue (ttm)
$2.85M
Revenue Growth
+241.73%
P/S Ratio
0.70
Revenue / Employee
$285,000
Employees
10
Market Cap
1.99M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 2.28M | 1.53M | 203.59% |
Dec 31, 2022 | 752.00K | -943.00K | -55.63% |
Dec 31, 2021 | 1.70M | 1.07M | 172.07% |
Dec 31, 2020 | 623.00K | 93.00K | 17.55% |
Dec 31, 2019 | 530.00K | 212.00K | 66.67% |
Dec 31, 2018 | 318.00K | 79.00K | 33.05% |
Dec 31, 2017 | 239.00K | 10.00K | 4.37% |
Dec 31, 2016 | 229.00K | 82.00K | 55.78% |
Dec 31, 2015 | 147.00K | -56.00K | -27.59% |
Dec 31, 2014 | 203.00K | -8.00K | -3.79% |
Dec 31, 2013 | 211.00K | 45.00K | 27.11% |
Dec 31, 2012 | 166.00K | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
cbdMD | 21.58M |
Nuwellis | 8.90M |
InMed Pharmaceuticals | 5.63M |
SCWorx | 3.92M |
SciSparc | 2.88M |
Azitra | 572.70K |
IMAC Holdings | -2.09M |
NAOV News
- 5 weeks ago - NanoVibronix Announces Commencement of UroShield Clinical Study at the University of Michigan - Business Wire
- 6 weeks ago - NanoVibronix Issues Letter to Stockholders - Business Wire
- 7 weeks ago - NanoVibronix Announces Distribution Agreement with VA Supplier CB Medical for the Distribution of UroShield - Business Wire
- 2 months ago - NanoVibronix Announces PainShield Will Be Included in Department of Veteran Affairs' FSS Contract Award - Business Wire
- 2 months ago - NanoVibronix to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 - Accesswire
- 3 months ago - NanoVibronix Signs Agreement for Research and Development of Next Generation PainShield and UroShield - Business Wire
- 7 months ago - NanoVibronix Featured in Your Bladder Health Magazine - Business Wire
- 7 months ago - NanoVibronix Enters into Letter of Intent with APOGEPHA Arzneimittel GmbH to Explore European Distribution Opportunity - Business Wire